Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice

Journal of Physiology and Pharmacology

Volumn 58, Issue 4, 2007, Pages 683-698

  Huebbe, P ^a   Jofre Monseny, L ^a   Boesch Saadatmandi, Ch ^a   Minihane, A M ^b   Rimbach, G ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

apoE genotype; Brain; Lipid peroxidation; Neurones; Oxidative status; Tocopherols and tocotrienols; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; GAMMA TOCOPHEROL; GLUTATHIONE; MEMBRANE LIPID;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN HOMOGENATE; BRAIN NERVE CELL; CONTROLLED STUDY; DIET RESTRICTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; TARGET CELL; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BRAIN; CELL DEATH; CELL LINE, TUMOR; FEMALE; GAMMA-TOCOPHEROL; GENOTYPE; HUMANS; LIPID PEROXIDATION; MICE; MICE, TRANSGENIC; NEURONS; NITRIC OXIDE; OXIDATIVE STRESS; TOCOTRIENOLS; VITAMIN E;

EID: 38149125627     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ramassamy C, Averill D, Beffert U, et al. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med 1999; 27: 544-553.
2. Styczynska M, Religa D, Pfeffer A, et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003; 344: 99-102.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697-699.
5. Marcus DL, Thomas C, Rodriguez C, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998; 150: 40-44.
6. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 2006; 103: 5644-5651.
7. Ramassamy C, Averill D, Beffert U, et al. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 2000; 7: 23-37.
8. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996; 14: 55-61.
9. Ihara Y, Hayabara T, Sasaki K, Kawada R, Nakashima Y, Kuroda S. Relationship between oxidative stress and apoE phenotype in Alzheimer's disease. Acta Neurol Scand 2000; 102: 346-349.
10. Colton CA, Brown CM, Cook D, et al. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 2002; 23: 777-785.
11. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997; 336: 1216-1222.
12. Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12: 121-126.
13. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 1998; 18: 8047-8055.
14. Peroutka SJ, Dreon DM. The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation. Eur J Pharmacol 2000; 410: 161-163.
15. Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-124.
16. Jofre-Monseny L, de Pascual-Teresa S, Plonka E, et al. Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages. Br J Nutr 2007; 97: 864-871.
17. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
18. Johansson LH, Borg LA. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 1988; 174: 331-336.
19. Cohen MB, Duvel DL. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochem Pharmacol 1988; 37: 3317-3320.
20. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976; 71: 952-958.
21. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106: 207-212.
22. Stoll L, Schubert T, Muller WE. Age-related deficits of central muscarinic cholinergic receptor function in the mouse: partial restoration by chronic piracetam treatment. Neurobiol Aging 1992; 13: 39-44.
23. Pap EH, Drummen GP, Winter VJ, et al. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591). FEBS Lett 1999; 453: 278-282.
24. Van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994; 7: 74-78.
25. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994; 36: 747-751.
26. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 1997; 68: 2061-2069.
27. Markesbery WR, Carney JM. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999; 9: 133-146.
28. Thomas WE. Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev 1992; 17: 61-74.
29. Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 2006; 26: 4985-4994.
30. 2-induced neuronal apoptosis. J Neurochem 1999; 73: 1181-1188.
31. Lee Y, Aono M, Laskowitz D, Warner DS, Pearlstein RD. Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity. Neurochem Int 2004; 44: 107-118.
32. Qiu Z, Crutcher KA, Hyman BT, Rebeck GW. ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 2003; 122: 291-303.
33. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 1989; 2: 1547-1558.
34. Behl C, Davis J, Cole GM, Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 1992; 186: 944-950.
35. Schubert D, Kimura H, Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci U S A 1992; 89: 8264-8267.
36. Morrissey PA, Sheehy PJ. Optimal nutrition: vitamin E. Proc Nutr Soc 1999; 58: 459-468.
37. Brigelius-Flohe R, Traber MG. Vitamin E: function and metabolism. Faseb J 1999; 13: 1145-1155.
38. Rush GF, Gorski JR, Ripple MG, Sowinski J, Bugelski P, Hewitt WR. Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes. Toxicol Appl Pharmacol 1985; 78: 473-483.
39. Gao R, Stone WL, Huang T, Papas AM, Qui M. The uptake of tocopherols by RAW 264.7 macrophages. Nutr J 2002; 1: 2.
40. Sen CK, Khanna S, Roy S, Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem 2000; 275: 13049-13055.
41. Meij JT, Haselton CL, Hillman KL, Muralikrishnan D, Ebadi M, Yu L. Differential mechanisms of nitric oxide- and peroxynitrite-induced cell death. Mol Pharmacol 2004; 66: 1043-1053.
42. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997; 94: 3217-3222.
43. Osakada F, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A. Alpha-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacology 2004; 47: 904-915.
44. Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 2002; 277: 25290-25296.
45. Tamaoka A, Miyatake F, Matsuno S, Ishii K, Nagase S, Sahara N, et al. Apolipoprotein E alleledependent antioxidant activity in brains with Alzheimer's disease. Neurology 2000; 54: 2319-2321.
46. Montine KS, Reich E, Neely MD, et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J Neuropathol Exp Neurol 1998; 57: 415-425.
47. Aybek H, Ercan F, Asian D, Sahiner T. Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clin Biochem 2007; 40: 172-176.
48. Rota C, Rimbach G, Minihane AM, Stoecklin E, Barella L. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci 2005; 8: 21-29.
49. Fischer A, Pallauf J, Gohil K, Weber SU, Packer L, Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem Biophys Res Commun 2001; 285: 470-475.
50. Rimbach G, Fischer A, Stoecklin E, Barella L. Modulation of hepatic gene expression by alpha-tocopherol in cultured cells and in vivo. Ann N Y Acad Sci 2004; 1031: 102-108.